pn 202-791 has been researched along with calcimycin in 1 studies
| Studies (pn 202-791) | Trials (pn 202-791) | Recent Studies (post-2010) (pn 202-791) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 44 | 0 | 1 | 11,946 | 40 | 444 |
| Protein | Taxonomy | pn 202-791 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzpatrick, LA | 1 |
1 other study(ies) available for pn 202-791 and calcimycin
| Article | Year |
|---|---|
Differences in the actions of calcium versus lanthanum to influence parathyroid hormone release.
Topics: Animals; Calcimycin; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cattle; In Vitro Techniques; Kinetics; Lanthanum; Nicotinic Acids; Oxadiazoles; Parathyroid Glands; Parathyroid Hormone; Pertussis Toxin; Virulence Factors, Bordetella | 1990 |